Cargando…
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience
PURPOSE: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. METHODS AND MATERIALS: Eighty-nine patients with SDC were treated with curative intent from February 5, 1971, through September 15, 2018. Kaplan-Meier a...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157113/ https://www.ncbi.nlm.nih.gov/pubmed/37152485 http://dx.doi.org/10.1016/j.adro.2023.101204 |
_version_ | 1785036678501498880 |
---|---|
author | Laughlin, Brady S. Ebrahimi, Sasha Voss, Molly M. Patel, Samir H. Foote, Robert L. McGee, Lisa A. Garcia, Joaquin Ma, Daniel J. Garces, Yolanda I. Wittich, Michelle A. Neben Price, Katharine A. Schmitt, Alessandra Zhai, Qihui May, Byron C. Nagel, Thomas H. Hinni, Michael L. Chintakuntlawar, Ashish V. DeWees, Todd A. Rwigema, Jean-Claude M. |
author_facet | Laughlin, Brady S. Ebrahimi, Sasha Voss, Molly M. Patel, Samir H. Foote, Robert L. McGee, Lisa A. Garcia, Joaquin Ma, Daniel J. Garces, Yolanda I. Wittich, Michelle A. Neben Price, Katharine A. Schmitt, Alessandra Zhai, Qihui May, Byron C. Nagel, Thomas H. Hinni, Michael L. Chintakuntlawar, Ashish V. DeWees, Todd A. Rwigema, Jean-Claude M. |
author_sort | Laughlin, Brady S. |
collection | PubMed |
description | PURPOSE: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. METHODS AND MATERIALS: Eighty-nine patients with SDC were treated with curative intent from February 5, 1971, through September 15, 2018. Kaplan-Meier and competing risk analyses were used to estimate locoregional control, distant metastasis-free survival (DMFS), progression-free survival, and overall survival (OS). Cox regression analyses of disease and treatment characteristics were performed to discover predictors of locoregional control, DMFS, and OS. RESULTS: Median follow-up was 44.1 months (range, 0.23-356.67). The median age at diagnosis was 66 years (interquartile range, 57-75). Curative surgery followed by adjuvant radiation therapy was performed in 73 patients (82%). Chemotherapy was delivered in 26 patients (29.2%). The 5-year local recurrence and distant metastasis rates were 27% and 44%, respectively, with death as a competing risk. Distant metastasis was associated with lymph node–positive disease (hazard ratio [HR], 3.16; 95% confidence interval [CI], 1.38-7.23; P = .006), stage IV disease (HR, 4.78; 95% CI, 1.14-20.11; P = .033), perineural invasion (HR, 4.56; 95% CI, 1.74-11.97; P = .002), and positive margins (HR, 9.06; 95% CI, 3.88-21.14; P < .001). Median OS was 4.84 years (95% CI, 3.54-7.02). The 5-year OS was 42%. Reduced OS was associated with lymphovascular space invasion (HR, 3.49; 95% CI, 1.2-10.1; P = .022), perineural invasion (HR, 2.05; 95% CI, 1.06-3.97; P = .033), positive margins (HR, 2.7; 95% CI, 1.3-5.6; P = .011), N2 disease (HR, 1.88; 95% CI, 1.03-3.43; P = .04), and N3 disease (HR, 11.76; 95% CI, 3.19-43.3; P < .001). CONCLUSIONS: In this single-institution, multicenter retrospective study, the 5-year survival was 42% in patients with SDC. Lymphovascular space invasion, lymph node involvement, and higher staging at diagnosis were associated with lower DMFS and OS. |
format | Online Article Text |
id | pubmed-10157113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101571132023-05-05 Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience Laughlin, Brady S. Ebrahimi, Sasha Voss, Molly M. Patel, Samir H. Foote, Robert L. McGee, Lisa A. Garcia, Joaquin Ma, Daniel J. Garces, Yolanda I. Wittich, Michelle A. Neben Price, Katharine A. Schmitt, Alessandra Zhai, Qihui May, Byron C. Nagel, Thomas H. Hinni, Michael L. Chintakuntlawar, Ashish V. DeWees, Todd A. Rwigema, Jean-Claude M. Adv Radiat Oncol Scientific Article PURPOSE: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. METHODS AND MATERIALS: Eighty-nine patients with SDC were treated with curative intent from February 5, 1971, through September 15, 2018. Kaplan-Meier and competing risk analyses were used to estimate locoregional control, distant metastasis-free survival (DMFS), progression-free survival, and overall survival (OS). Cox regression analyses of disease and treatment characteristics were performed to discover predictors of locoregional control, DMFS, and OS. RESULTS: Median follow-up was 44.1 months (range, 0.23-356.67). The median age at diagnosis was 66 years (interquartile range, 57-75). Curative surgery followed by adjuvant radiation therapy was performed in 73 patients (82%). Chemotherapy was delivered in 26 patients (29.2%). The 5-year local recurrence and distant metastasis rates were 27% and 44%, respectively, with death as a competing risk. Distant metastasis was associated with lymph node–positive disease (hazard ratio [HR], 3.16; 95% confidence interval [CI], 1.38-7.23; P = .006), stage IV disease (HR, 4.78; 95% CI, 1.14-20.11; P = .033), perineural invasion (HR, 4.56; 95% CI, 1.74-11.97; P = .002), and positive margins (HR, 9.06; 95% CI, 3.88-21.14; P < .001). Median OS was 4.84 years (95% CI, 3.54-7.02). The 5-year OS was 42%. Reduced OS was associated with lymphovascular space invasion (HR, 3.49; 95% CI, 1.2-10.1; P = .022), perineural invasion (HR, 2.05; 95% CI, 1.06-3.97; P = .033), positive margins (HR, 2.7; 95% CI, 1.3-5.6; P = .011), N2 disease (HR, 1.88; 95% CI, 1.03-3.43; P = .04), and N3 disease (HR, 11.76; 95% CI, 3.19-43.3; P < .001). CONCLUSIONS: In this single-institution, multicenter retrospective study, the 5-year survival was 42% in patients with SDC. Lymphovascular space invasion, lymph node involvement, and higher staging at diagnosis were associated with lower DMFS and OS. Elsevier 2023-03-01 /pmc/articles/PMC10157113/ /pubmed/37152485 http://dx.doi.org/10.1016/j.adro.2023.101204 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Laughlin, Brady S. Ebrahimi, Sasha Voss, Molly M. Patel, Samir H. Foote, Robert L. McGee, Lisa A. Garcia, Joaquin Ma, Daniel J. Garces, Yolanda I. Wittich, Michelle A. Neben Price, Katharine A. Schmitt, Alessandra Zhai, Qihui May, Byron C. Nagel, Thomas H. Hinni, Michael L. Chintakuntlawar, Ashish V. DeWees, Todd A. Rwigema, Jean-Claude M. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title | Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title_full | Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title_fullStr | Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title_full_unstemmed | Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title_short | Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience |
title_sort | clinicopathologic factors and their association with outcomes of salivary duct carcinoma: a multicenter experience |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157113/ https://www.ncbi.nlm.nih.gov/pubmed/37152485 http://dx.doi.org/10.1016/j.adro.2023.101204 |
work_keys_str_mv | AT laughlinbradys clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT ebrahimisasha clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT vossmollym clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT patelsamirh clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT footerobertl clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT mcgeelisaa clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT garciajoaquin clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT madanielj clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT garcesyolandai clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT wittichmichelleaneben clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT pricekatharinea clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT schmittalessandra clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT zhaiqihui clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT maybyronc clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT nagelthomash clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT hinnimichaell clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT chintakuntlawarashishv clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT deweestodda clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience AT rwigemajeanclaudem clinicopathologicfactorsandtheirassociationwithoutcomesofsalivaryductcarcinomaamulticenterexperience |